BE905957A - Nouveau facteur pour la regulation de la croissance cellulaire. - Google Patents

Nouveau facteur pour la regulation de la croissance cellulaire.

Info

Publication number
BE905957A
BE905957A BE0/217546A BE217546A BE905957A BE 905957 A BE905957 A BE 905957A BE 0/217546 A BE0/217546 A BE 0/217546A BE 217546 A BE217546 A BE 217546A BE 905957 A BE905957 A BE 905957A
Authority
BE
Belgium
Prior art keywords
cell growth
human
regulating cell
cultured
new factor
Prior art date
Application number
BE0/217546A
Other languages
English (en)
Original Assignee
Oncogen Soc En Commandite
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen Soc En Commandite filed Critical Oncogen Soc En Commandite
Publication of BE905957A publication Critical patent/BE905957A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Nouvelles compositions pour régulation de la croissance cellulaire, obtenues à partir de leucocytes, p. ex. lymphocytes de sang périphérique humain ou lignées de lymphomes histiocytiques humains cultivés avec un ou des inducteurs. Le peptide apparaissant naturellement est obtenu par purification du milieu conditionné de ces cellules et possède une activité d'inhibition ou de stimulation sélectives pour certaines lignées de cellules. Le polypeptide est isolé à partir de milieux conditionnés de LSP humains cultivés ou de lignées de cellules de lymphomes histiocytiques, est synthétisé ou est préparé par clonage du gène dans un hote approprié.
BE0/217546A 1985-12-20 1986-12-17 Nouveau facteur pour la regulation de la croissance cellulaire. BE905957A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81123585A 1985-12-20 1985-12-20
US93528386A 1986-11-26 1986-11-26

Publications (1)

Publication Number Publication Date
BE905957A true BE905957A (fr) 1987-06-17

Family

ID=27123452

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/217546A BE905957A (fr) 1985-12-20 1986-12-17 Nouveau facteur pour la regulation de la croissance cellulaire.

Country Status (29)

Country Link
JP (1) JP2559035B2 (fr)
KR (1) KR920005920B1 (fr)
CN (1) CN1017626B (fr)
AT (1) AT400444B (fr)
AU (2) AU601168B2 (fr)
BE (1) BE905957A (fr)
CA (1) CA1340296C (fr)
CH (1) CH675727A5 (fr)
CY (1) CY1608A (fr)
DE (2) DE3645095C2 (fr)
DK (1) DK174094B1 (fr)
ES (1) ES2003180A6 (fr)
FI (1) FI91484C (fr)
FR (1) FR2597108B1 (fr)
GB (1) GB2185485B (fr)
GR (1) GR862936B (fr)
HK (1) HK65691A (fr)
HU (1) HU210694B (fr)
IE (1) IE59415B1 (fr)
IL (1) IL81017A (fr)
IT (1) IT1213428B (fr)
LU (1) LU86718A1 (fr)
NL (1) NL8603209A (fr)
NO (1) NO174556C (fr)
NZ (1) NZ218634A (fr)
OA (1) OA08494A (fr)
PT (1) PT83986B (fr)
SE (1) SE505059C2 (fr)
SG (1) SG60891G (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
US5681930A (en) * 1985-12-20 1997-10-28 Bristol-Myers Squibb Company Anti-oncostatin M monoclonal antibodies
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
IL97622A (en) * 1990-03-29 1997-06-10 Oncogen Limited Partnership Se Monoclonal antibodies that inhibit growth of kaposi's sarcoma
IL97623A (en) * 1990-03-29 1996-01-19 Bristol Myers Squibb Co Anti-oncostatin m monoclonal antibodies their preparation and pharmaceutical compositions containing them
WO1992002556A1 (fr) * 1990-08-02 1992-02-20 Michael Valentine Agrez Facteur d'elongation de fibroblastes derive des cellules cancereuses du colon humain
IL107040A0 (en) * 1992-09-25 1993-12-28 Lilly Co Eli Modified platelet factor-4

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits

Also Published As

Publication number Publication date
IT1213428B (it) 1989-12-20
CN1017626B (zh) 1992-07-29
ATA340686A (de) 1995-05-15
DK615386A (da) 1987-06-21
PT83986A (en) 1987-01-01
IL81017A0 (en) 1987-03-31
HUT43103A (en) 1987-09-28
IE863345L (en) 1987-06-20
CA1340296C (fr) 1998-12-29
ES2003180A6 (es) 1988-10-16
KR920005920B1 (ko) 1992-07-24
FR2597108A1 (fr) 1987-10-16
CY1608A (en) 1992-04-03
DE3643428A1 (de) 1987-09-24
NO865178L (no) 1987-06-22
SE8605459D0 (sv) 1986-12-18
NZ218634A (en) 1991-06-25
NO174556C (no) 1994-05-25
DK174094B1 (da) 2002-06-10
HU210694B (en) 1995-06-28
GB2185485B (en) 1990-07-04
SG60891G (en) 1991-08-23
JP2559035B2 (ja) 1996-11-27
SE505059C2 (sv) 1997-06-16
OA08494A (fr) 1988-07-29
GB2185485A (en) 1987-07-22
AT400444B (de) 1995-12-27
HK65691A (en) 1991-08-23
NO174556B (no) 1994-02-14
AU601168B2 (en) 1990-09-06
IT8622787A0 (it) 1986-12-19
AU6660886A (en) 1987-06-25
FR2597108B1 (fr) 1991-02-15
JPS62236498A (ja) 1987-10-16
CN86108955A (zh) 1987-12-02
IE59415B1 (en) 1994-02-23
AU6776590A (en) 1991-03-14
FI865156L (fi) 1987-06-21
SE8605459L (sv) 1987-06-21
DE3643428C2 (fr) 1990-08-23
NO865178D0 (no) 1986-12-19
DK615386D0 (da) 1986-12-18
DE3645095C2 (de) 1993-11-18
GR862936B (en) 1987-10-28
NL8603209A (nl) 1987-07-16
IL81017A (en) 1993-01-14
KR870005645A (ko) 1987-07-06
LU86718A1 (fr) 1988-07-14
PT83986B (pt) 1989-07-31
FI91484B (fi) 1994-03-31
AU639048B2 (en) 1993-07-15
CH675727A5 (fr) 1990-10-31
FI865156A0 (fi) 1986-12-17
GB8629997D0 (en) 1987-01-28
FI91484C (fi) 1994-07-11

Similar Documents

Publication Publication Date Title
Chan et al. A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia positive acute lymphoblastic leukaemia
Bartram et al. Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia
ATE153382T1 (de) Rekombinantes dns-verfahren und wirtszellen
ATE64416T1 (de) Die verwendung des gal 1 hefe-promotors.
IL76625A0 (en) Substituted propane-phosphonous acid compounds
DE69032406D1 (de) Wundheilmittel enthaltend heparanase
BE887529A (fr) Polypeptide preparer, par voie microbiologique avec sequence d'informations genetiques, microorganismes contenant ces informations genetiques et leur procedes de preparation
NZ313474A (en) Root cortex specific gene promoter
DK540685D0 (da) Blodpladepeptidbeslaegtet vaekstregulator
BE905957A (fr) Nouveau facteur pour la regulation de la croissance cellulaire.
DE69333079D1 (de) Expressionskassette und plasmid für eine expression spezifisch für schliesszellen und ihre verwendung zur einführung in transgene pflanzenzellen und pflanzen
NO177270C (no) Fremg. for fremstilling av terapeutisk aktive, humane granulocytt-makrofag-"kolonistimulerende"-faktorproteiner (GM-CSF), bakteriell ekspresjonvektor som er i stand til å uttrykke GM-CSF samt bakteriecelle inneholdende vektoren
KR880000590A (ko) 생물학적 활성 플라스미노겐 활성제의 제조방법
Berg et al. Increased protein binding to a− 530 mutation of the human β‐globin gene associated with decreased β‐globin synthesis
ATE123061T1 (de) Wachstumsregler zusammenhängend mit blutplättchen.
ATE86635T1 (de) Reinigung von rekombinantem interleukin-1.
KR900702009A (ko) 인체 a형 모노아민 옥시다제를 코오딩 하는 dna
ATE52540T1 (de) Verwendung von glutamin in form seiner di- und tripeptide im naehrmedium fuer zellkulturen.
Cohen et al. Linkage between blood coagulation and inflammation: stimulation of neutrophil tissue kallikrein by thrombin
Minato et al. Regulation of the growth and functions of cloned murine large granular lymphocyte lines by resident macrophages.
Cox et al. Assignment of the gene for beta 2-microglobulin (B2m) to mouse chromosome 2.
SILLETTI et al. Autocrine motility factor-receptor in human bladder-carcinoma-gene-expression, loss of cell-contact regulation and chromosomal mapping
ES8707565A1 (es) Un procedimiento para producir un anticuerpo monoclonal
EP0154566A3 (en) Viral enhancer dna segments
Ceratto et al. Human type I cytokeratin genes are a compact cluster

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *ONCOGEN SOC.EN COMMANDITE

Effective date: 20061217